RON(MST1R)is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma

From Concept to Reality: The Long Road to c-Met and RON Receptor Tyrosine Kinase Inhibitors for the Treatment of Cancer

(2012) Isabelle Dussault et al.   Anti-Cancer Agents in Medicinal Chemistry

MET, HGF, EGFR, and PXN Gene Copy Number in Lung Cancer Using DNA Extracts from FFPE Archival Samples and Prognostic Significance

(2012) Rajani Kanteti et al.   JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY

Discovery of a Novel Mode of Protein Kinase Inhibition Characterized by the Mechanism of Inhibition of Human Mesenchymal-epithelial Transition Factor (c-Met) Protein Autophosphorylation by ARQ 197

(2011) Sudharshan Eathiraj et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Molecular Profiling of Cancer—The Future of Personalized Cancer Medicine: A Primer on Cancer Biology and the Tools Necessary to Bring Molecular Testing to the Clinic

(2011) Thomas Stricker et al.   SEMINARS IN ONCOLOGY

Gastric cancer cell line Hs746T harbors a splice site mutation of c-Met causing juxtamembrane domain deletion

(2010) Yoshinari Asaoka et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

MET and KRAS Gene Amplification Mediates Acquired Resistance to MET Tyrosine Kinase Inhibitors

(2010) V. Cepero et al.   CANCER RESEARCH

Development of an Integrated Genomic Classifier for a Novel Agent in Colorectal Cancer: Approach to Individualized Therapy in Early Development

(2010) T. M. Pitts et al.   CLINICAL CANCER RESEARCH

The Macrophage Stimulating Protein/Ron Pathway as a Potential Therapeutic Target to Impede Multiple Mechanisms Involved in Breast Cancer Progression

(2010) Kelsi L. Kretschmann et al.   CURRENT DRUG TARGETS

Clinical Cancer Advances 2010: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

(2010) Mark G. Kris et al.   JOURNAL OF CLINICAL ONCOLOGY

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

(2010) Yung-Jue Bang et al.   LANCET

ARQ 197, a Novel and Selective Inhibitor of the Human c-Met Receptor Tyrosine Kinase with Antitumor Activity

(2010) N. Munshi et al.   MOLECULAR CANCER THERAPEUTICS

STAT-3 correlates with lymph node metastasis and cell survival in gastric cancer

(2010) Jing-Yu Deng   WORLD JOURNAL OF GASTROENTEROLOGY

Recent advances in chemotherapy for advanced gastric cancer

(2010) Jong Gwang Kim   World Journal of Gastrointestinal Oncology

Expression of activated signal transducer and activator of transcription 3 predicts poor clinical outcome in gastric adenocarcinoma

(2009) JEEYUN LEE et al.   APMIS

The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments

(2009) S. A. Bustin et al.   CLINICAL CHEMISTRY

Knockdown of Ron Kinase Inhibits Mutant Phosphatidylinositol 3-Kinase and Reduces Metastasis in Human Colon Carcinoma

(2009) Jing Wang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

IncreasedMETGene Copy Number Negatively Affects Survival of Surgically Resected Non–Small-Cell Lung Cancer Patients

(2009) Federico Cappuzzo et al.   JOURNAL OF CLINICAL ONCOLOGY

EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancer

(2009) M Varella-Garcia et al.   JOURNAL OF CLINICAL PATHOLOGY

A survey of the population genetic variation in the human kinome

(2009) Wei Zhang et al.   JOURNAL OF HUMAN GENETICS

The Ron receptor tyrosine kinase positively regulates angiogenic chemokine production in prostate cancer cells

(2009) M N Thobe et al.   ONCOGENE

Gastric cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

(2008) D. Cunningham et al.   ANNALS OF ONCOLOGY

Fluorescence Imaging of Membrane Dynamics

(2008) Jay T. Groves et al.   Annual Review of Biomedical Engineering

Fluorescence Proteins, Live-Cell Imaging, and Mechanobiology: Seeing Is Believing

(2008) Yingxiao Wang et al.   Annual Review of Biomedical Engineering

Expression of the RON receptor tyrosine kinase and its association with gastric carcinoma versus normal gastric tissues

(2008) Donghui Zhou et al.   BMC CANCER

MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival

(2008) H. Jin et al.   CANCER RESEARCH

Paxillin Is a Target for Somatic Mutations in Lung Cancer: Implications for Cell Growth and Invasion

(2008) R. Jagadeeswaran et al.   CANCER RESEARCH

MicroRNAs Impair MET-Mediated Invasive Growth

(2008) C. Migliore et al.   CANCER RESEARCH

Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC) - gastrointestinal cancer group

(2008) Eric Van Cutsem et al.   EUROPEAN JOURNAL OF CANCER

Assessment of a HER2 scoring system for gastric cancer: results from a validation study

(2008) M Hofmann et al.   HISTOPATHOLOGY

Smad4-dependent TGF-β Signaling Suppresses RON Receptor Tyrosine Kinase-dependent Motility and Invasion of Pancreatic Cancer Cells

(2008) Shujie Zhao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

STAT3 expression in gastric cancer indicates a poor prognosis

(2008) Dae-Young Kim et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

EGFR FISH in colorectal cancer: what is the current reality?

(2008) Mauro Moroni et al.   LANCET ONCOLOGY

The RON receptor tyrosine kinase promotes MSP-independent cell spreading and survival in breast epithelial cells

(2008) K J Feres et al.   ONCOGENE